Literature DB >> 24574049

Activation of ErbB2- ErbB3 signaling pathway supports potential therapeutic activity of ErbB inhibitors in AT/RT.

Simone Treiger Sredni1, Kashyap Patel, Felipe D'Almeida Costa, Maria de Fátima Bonaldo, Tadanori Tomita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24574049     DOI： 10.1007/s11060-014-1406-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  3 in total

1.  A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study.

Authors:  Maryam Fouladi; Clinton F Stewart; Susan M Blaney; Arzu Onar-Thomas; Paula Schaiquevich; Roger J Packer; Stewart Goldman; J Russell Geyer; Amar Gajjar; Larry E Kun; James M Boyett; Richard J Gilbertson
Journal:  J Neurooncol       Date:  2013-07-09       Impact factor: 4.130

2.  Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study.

Authors:  Maryam Fouladi; Clinton F Stewart; Susan M Blaney; Arzu Onar-Thomas; Paula Schaiquevich; Roger J Packer; Amar Gajjar; Larry E Kun; James M Boyett; Richard J Gilbertson
Journal:  J Clin Oncol       Date:  2010-08-16       Impact factor: 44.544

3.  Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinib.

Authors:  Anjali Singh; Xueqing Lun; Aarthi Jayanthan; Halah Obaid; Yibing Ruan; Douglas Strother; Susan N Chi; Amy Smith; Peter Forsyth; Aru Narendran
Journal:  Mol Oncol       Date:  2013-01-11       Impact factor: 6.603
  3 in total
  3 in total

1.  Overexpression of ERBB3 promotes proliferation, migration, and angiogenesis in nasopharyngeal carcinoma.

Authors:  Bingyue Duan; Ziyu Zhu; Bo You; Si Shi; Ying Shan; Pan Jiang; Qicheng Zhang; Lili Bao; Yong Yin; Yiwen You
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

Review 2.  Atypical teratoid/rhabdoid tumors: challenges and search for solutions.

Authors:  Ahitagni Biswas; Lakhan Kashyap; Aanchal Kakkar; Chitra Sarkar; Pramod Kumar Julka
Journal:  Cancer Manag Res       Date:  2016-09-16       Impact factor: 3.989

3.  Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors.

Authors:  Betty Tyler; Nicolas Skuli; Joshua Casaos; Sakibul Huq; Tarik Lott; Raphael Felder; John Choi; Noah Gorelick; Michael Peters; Yuanxuan Xia; Russell Maxwell; Tianna Zhao; Chenchen Ji; Thomas Simon; Julie Sesen; Sarah J Scotland; Richard E Kast; Jeffrey Rubens; Eric Raabe; Charles G Eberhart; Eric M Jackson; Henry Brem
Journal:  Oncotarget       Date:  2018-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.